GI Stool Testing Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030

The global GI stool testing market is anticipated to grow at a considerable CAGR of 7.1% during the forecast period. Gastrointestinal infections (GI) are caused by a variety of viruses, bacteria, and parasites. The gastrointestinal pathogen panel simultaneously tests for the presence of multiple disease-causing (pathogenic) microbes in a stool sample. The GI pathogen panel detects the genetic material (RNA or DNA) of some of the more common pathogens. It can identify co-infections (more than one microbe causing the infection) and identify microbes that might be missed with traditional testing. The rising prevalence of diarrhea across the globe is expected to raise the demand for the GI stool testing market during the forecast period. For instance, according to the World Health Organization, diarrheal disease is the second leading cause of death in children under five years old. Globally, there are nearly 1.7 billion cases of childhood diarrheal disease every year. Moreover, each year diarrhea kills around 5,25,000 children under five.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/gi-stool-testing-market

The technological advancements by market players across the globe are expected to hold a prominent share of the market during the forecast period. For instance, in January 2022, Exact Sciences Corp. announced performance data for a second-generation Cologuard (multi-target stool DNA) test showing overall sensitivity of 95.2% for colorectal cancer (CRC) at the specificity of 92.4% for negative samples confirmed by colonoscopy. Furthermore, Cologuard is the first and only FDA-approved, non-invasive stool DNA test used to screen average-risk people for CRC. Exact Sciences is developing a second-generation Cologuard to improve the specificity and precancer sensitivity of the test, decreasing the false positive rate and increasing the detection rate of precancerous lesions.

Global GI Stool Testing Market Report Segment

By Product Type

Instruments
Reagents)

By Test Type

Microscopy
Occult Blood Test
Ova and Parasites Test
Bacteria Test
Fecal Biomarkers Test
Other Test Types

By End-Users

Hospitals
Home
Diagnostic Centers & Laboratories
Academic Institutions and Research Centers

A full report of GI Stool Testing Market is available at: https://www.omrglobal.com/industry-reports/gi-stool-testing-market

GI Stool Testing Market- Segment by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

Abbott Laboratories
Alere, Inc.
Beckman Coulter Inc.
bioMerieux SA
Biometrix Labs
Bio-Rad Laboratories
Cardinal Health, Inc.
Cenogenics Corp.
CTK Biotech Inc.
Danaher Corp.
DiaSorin S.p.A
Diagnostic Solutions Laboratory, LLC
Epitope Diagnostics Inc.

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.